Related references
Note: Only part of the references are listed.Downregulation of long noncoding RNA MEG3 is associated with poor prognosis and promoter hypermethylation in cervical cancer
Jun Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Aberrant Methylation-Mediated Silencing of lncRNA MEG3 Functions as a ceRNA in Esophageal Cancer
Zhiming Dong et al.
MOLECULAR CANCER RESEARCH (2017)
MET/SMAD3/SNAIL circuit mediated by miR-323a-3p is involved in regulating epithelial-mesenchymal transition progression in bladder cancer
Jiangfeng Li et al.
CELL DEATH & DISEASE (2017)
Aberrant Methylation of MEG3 Functions as a Potential Plasma-Based Biomarker for Cervical Cancer
Jun Zhang et al.
SCIENTIFIC REPORTS (2017)
Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21
Jun Zhang et al.
CANCER BIOLOGY & THERAPY (2016)
Decreased expression of MEG3 contributes to retinoblastoma progression and affects retinoblastoma cell growth by regulating the activity of Wnt/β-catenin pathway
Yali Gao et al.
TUMOR BIOLOGY (2016)
Long Noncoding RNA EWSAT1 Promotes Osteosarcoma Cell Growth and Metastasis Through Suppression of MEG3 Expression
Lishan Sun et al.
DNA AND CELL BIOLOGY (2016)
Expression of the IncRNA Maternally Expressed Gene 3 (MEG3) Contributes to the Control of Lung Cancer Cell Proliferation by the Rb Pathway
Traci L. Kruer et al.
PLOS ONE (2016)
MiR-141 Inhibits Gastric Cancer Proliferation by Interacting with Long Noncoding RNA MEG3 and Down-Regulating E2F3 Expression
Xiaoying Zhou et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Epigenetically silenced long noncoding-SRHC promotes proliferation of hepatocellular carcinoma
Hao Zheng et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)
MEG3 noncoding RNA: a tumor suppressor
Yunli Zhou et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2012)
The hallmarks of cancer A long non-coding RNA point of view
Tony Gutschner et al.
RNA BIOLOGY (2012)
Promoter methylation and downregulation of SLC22A18 are associated with the development and progression of human glioma
Sheng-Hua Chu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Cancer epigenetics reaches mainstream oncology
Manuel Rodriguez-Paredes et al.
NATURE MEDICINE (2011)
Maternally Expressed Gene 3, an Imprinted Noncoding RNA Gene, Is Associated with Meningioma Pathogenesis and Progression
Xun Zhang et al.
CANCER RESEARCH (2010)
The IG-DMR and the MEG3-DMR at Human Chromosome 14q32.2: Hierarchical Interaction and Distinct Functional Properties as Imprinting Control Centers
Masayo Kagami et al.
PLOS GENETICS (2010)
Incidence of retinoblastoma in the USA: 1975-2004
E. Broaddus et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2009)
Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia:: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour
D Astuti et al.
BRITISH JOURNAL OF CANCER (2005)
Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors
J Zhao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Identification of an imprinted gene, Meg3/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q
N Miyoshi et al.
GENES TO CELLS (2000)
Share Paper
